Antibodies binding to a C-terminal fragment of Apolipoprotein E

Details for Australian Patent Application No. 2004293180 (hide)

Owner AstraZeneca AB Dyax Corp.

Inventors Nordstedt, Christer; Hufton, Simon; Hoet, Rene; Sunnemark, Dan; Goldschmidt, Tom; Andersson, Christin V.; Lindquist, Johanna; Henderikx, Maria; Hoogenboom, Hendricus; Leonov, Sergy

Agent Spruson & Ferguson

Pub. Number AU-B-2004293180

PCT Pub. Number WO2005/051998

Priority 60/525,174 28.11.03 US

Filing date 26 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 15 September 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051998 Priority application(s): WO2005/051998

15 September 2011 Application Accepted

  Published as AU-B-2004293180

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293182-Compositions comprising polypeptides

2004293179-7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrah ydro-1H-3-benzazepinium maleate or tosylate as antipsychotics